Effect of Incretin Analogues and Dipeptidyl-peptidase-IV inhibitors on colorectal cancer risk

28/04/2015
27/03/2024
EU PAS number:
EUPAS9592
Study
Finalised
Documents
Study protocol
Initial protocol
English (258.61 KB - PDF) View document
Study results
Study results
English (525.13 KB - PDF) View document
Study report
Other information
Publications